NCT05594563 - TArgeting Type 1 Diabetes Using POLyamines (TADPOL) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

May 31, 2028

Conditions

Type 1 Diabetes

Interventions

DRUG

DFMO

DFMO orally twice a day

DRUG

Placebo

Placebo orally twice a day

Trial Locations (7)

RECRUITING

IU Health Riley Hospital for Children, Indianapolis

RECRUITING

University of Michigan, Ann Arbor

RECRUITING

Medical College of Wisconsin, Milwaukee

RECRUITING

MHealth Fairview Masonic Children's Hospital and Specialty Clinics, Minneapolis

RECRUITING

University of Chicago, Chicago

RECRUITING

Children's Mercy Hospital, Kansas City

RECRUITING

Barbara Davis Center, Aurora